Duchenne Muscular Dystrophy

Sarepta Surges on Optimism Over Muscular Dystrophy Drug
Bloomberg
Mon, 04/21/14 - 10:32 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics on Cusp of Huge Eteplirsen News
TheStreet.com
Tue, 04/8/14 - 05:16 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Prosensa jumps 30% after data from Phase 2 study of DMD drug
The Fly on the Wall
Tue, 03/18/14 - 09:01 am
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
Sarepta jumps on fresh optimism for an early approval
Fierce Biotech
Thu, 01/16/14 - 11:34 am
Sarepta
Duchenne Muscular Dystrophy
eteplirsen
GSK hands back failed muscular dystrophy drug to Prosensa
Yahoo/Reuters
Mon, 01/13/14 - 09:00 am
GSK
Prosensa
Duchenne Muscular Dystrophy
drisapersen
This FDA Letter About Sarepta and Accelerated Approval for Eteplirsen Will Blow Your Mind
TheStreet.com
Mon, 01/6/14 - 04:25 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Eteplirsen's Competitive Advantage Is Setting Up Sarepta For 2014
Seeking Alpha
Thu, 12/26/13 - 09:43 am
eteplirsen
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biotech Stock Roundup: Vanda Soars, Sarepta Slumps
Yahoo/Zacks.com
Wed, 11/20/13 - 11:47 am
Vanda
Sarepta Therapeutics
tasimelteon
Hetlioz
Duchenne Muscular Dystrophy
eteplirsen
Eteplirsen in Question: Hope for Sarepta
Motley Fool
Fri, 11/15/13 - 09:51 am
eteplirsen
Sarepta Therapeutics
Duchenne Muscular Dystrophy
What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech
Forbes
Tue, 11/12/13 - 04:32 pm
Duchenne Muscular Dystrophy
eteplirsen
Sarepta Therapeutics
Sarepta Serious Setback: FDA Says No Early Approval Filing for Eteplirsen
TheStreet.com
Tue, 11/12/13 - 07:59 am
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
Short Sarepta: DMD Drug Prognosis Is Dismal
Seeking Alpha
Wed, 10/30/13 - 09:35 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
This Slide Paints Grim Picture of Glaxo, Prosensa's DMD Drug
TheStreet.com
Mon, 10/7/13 - 08:57 am
GSK
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
eteplirsen
Sarepta still on track for eteplirsen NDA next year, says Piper Jaffray
Yahoo/Fly on the Wall
Fri, 10/4/13 - 12:40 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
3 Key Points From Sarepta's Eteplirsen Study Update (And They're Positive)
TheStreet.com
Thu, 09/26/13 - 10:35 am
Sarepta
eteplirsen
Genentech
GSK
Duchenne Muscular Dystrophy
Phase III Trial Ruins Prosensa's Drisapersen, Sarepta Rallies Strongly
Seeking Alpha
Mon, 09/23/13 - 10:37 am
Prosensa
Sarepta Therapeutics
drisapersen
GSK
Duchenne Muscular Dystrophy
The Good, the Bad, and the Ugly of a Competitor's Failure
Motley Fool
Sat, 09/21/13 - 10:11 am
GSK
Prosensa
Duchenne Muscular Dystrophy
muscular dystrophy
eteplirsen
Sarepta Therapeutics
GSK, Prosensa muscular dystrophy drug misses study goal
Reuters
Fri, 09/20/13 - 09:36 am
GSK
Prosensa
drisapersen
Duchenne Muscular Dystrophy
Sarepta shares jump after disappointing test for rival drug
Reuters
Fri, 08/16/13 - 10:33 am
Prosensa
drisapersen
Duchenne Muscular Dystrophy
GSK
Sarepta
eteplirsen
Potential Paradigm Shifting Technology from a Small Biotech
Motley Fool
Sat, 08/3/13 - 10:36 am
Sarepta Therapeutics
eteplirsen
muscular dystrophy
Duchenne Muscular Dystrophy

Pages